HAIs are a common complication of hospitalized patients and a leading complication among patients with stroke.
The grant will focus on developing novel, targeted, less toxic therapies for children with brain cancer.
Capers and Singleton will have opportunities to share information on teaching, mentoring and research, as well as on building a career in higher education.
Fast, inexpensive gene sequencing needed to make possible personalized medicine.
Grant will allow UAB researchers to study novel therapies for pulmonary fibrosis, a deadly lung disease with no approved treatments.
Yang’s research focuses on a new class of drug – PARP inhibitors – that interfere with a cancer cell’s ability to repair DNA damage, hastening cell death.
He recently co-wrote an opinion paper titled “Research Ethics and Geoengineering."
The UAB community came out to support the CPS-3, becoming the largest single site enrollment in the United States with 1,209 participants.